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Abstract 21 
Food protein hydrolysates contain peptide sequences with dipeptidyl peptidase IV (DPP-IV) 22 
inhibitory properties which may find use to improve serum glucose regulation in type 2 diabetics. 23 
Four plant protein isolates from hemp (H), pea (P), rice (R) and soy (S) were hydrolysed with 24 
three enzyme preparations: Corolase L10 (Cor), Promod 144MG (Prom) and Protamex (Prot). 25 
From the 12 hydrolysates generated after 4 h incubation, 7 yielded DPP-IV inhibitory activity < 26 
2.0 mg protein equivalent mL
-1
. Their IC50 values ranged from 0.73  0.11 to 3.54 ± 0.24 mg dw 27 
hydrolysate mL
-1
 for the 4 h P_Prot and 4 h H_Cor hydrolysates, respectively. Simulated 28 
gastrointestinal digestion (SGID) of the intact proteins yielded DPP-IV IC50 values between 1.85 29 
 0.34 to 4.50  0.55 mg dw hydrolysate mL-1 for the R and H, respectively. The DPP-IV 30 
inhibitory potency of the 4 h hydrolysates subjected to SGID (DPP-IV IC50 ranging from 1.00  31 
0.42 to 3.83  0.36 mg dw hydrolysate mL-1 for the SGID of the 4 h S_Prom and 4 h H_Prot, 32 
respectively) was generally higher than that of the corresponding intact protein subjected to 33 
SGID, with the exception of the SGID of R and that of the 4 h R_Prot hydrolysate which had 34 
similar IC50 values (P > 0.05). To our knowledge, this is the first study reporting that H and P 35 
protein hydrolysates inhibit DPP-IV in vitro. This study also demonstrates the potential benefit, 36 
in some instances, of hydrolysing plant protein substrates prior to oral ingestion with the view of 37 
releasing DPP-IV inhibitory peptides. 38 
 39 
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Introduction 43 
Dipeptidyl peptidase IV (DPP-IV) is an ubiquitous enzyme which is involved in the degradation 44 
of the incretin hormones, glucose dependent insulinotropic polypeptide (GIP) and glucagon-like 45 
peptide-1 (GLP-1) [1]. Degradation of GLP-1 and GIP by DPP-IV results in a loss in their ability 46 
to induce insulin secretion in pancreatic beta cells following nutrient intake [2; 3]. Inhibition of 47 
DPP-IV has been employed as a means to increase incretin half-life in order to maintain 48 
insulinotropic activity during the post-prandial phase. In this context, various DPP-IV inhibitory 49 
drugs, known as gliptins, have been developed for the treatment of type 2 diabetes (T2D). 50 
Gliptins generally have DPP-IV half maximum inhibitory concentration values in the nM range 51 
[4]. 52 
Natural alternatives to DPP-IV inhibitory drugs may exist in the diet. These include DPP-IV 53 
inhibitory peptide fragments which can be released following the hydrolysis of food proteins [5]. 54 
Based on in silico analyses, a wide range of food proteins have been reported to contain known 55 
DPP-IV inhibitory peptide sequences [6-8]. To date, milk proteins are the most studied substrate 56 
for the generation of DPP-IV inhibitory peptides [9-14]. Other food protein sources of DPP-IV 57 
inhibitory peptides include rice (R) [15], barley [16], amaranth [17], seaweed [18], tuna cooking 58 
juice [19], a dried-cured ham water soluble extract [20], Atlantic salmon [21] and porcine skin 59 
gelatin [22; 23]. DPP-IV inhibitory peptides from food proteins generally have IC50 values 60 
several orders of magnitude higher than that of gliptins. A well-known DPP-IV inhibitory 61 
peptide, Ile-Pro-Ile, which was originally discovered in microbial cultures of Bacillus cereus, has 62 
an IC50 value in the µM range [24]. This peptide sequence, known as diprotin A, can also be 63 
found within certain food proteins such as κ-casein, chicken egg ovotransferrin and the 64 
phycoerythrin β subunit from Palmaria palmata [8]. 65 
While different dietary proteins have been investigated for their DPP-IV inhibitory properties, 66 
most substrates described in the literature to date appear to originate from animal proteins. Plant 67 
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proteins are readily available and are generally more competitively priced compared to animal 68 
proteins. In addition, they can be consumed by people who do not eat or restrict animal protein 69 
intake in their diet (vegetarian/vegan, Kosher, Halal diet, etc.). Plant proteins have been shown to 70 
have a wide range of bioactivities mainly for their antioxidant and antihypertensive properties 71 
[25-28]. DPP-IV inhibition has been reported with R protein hydrolysates and several dipeptides 72 
with a Pro residue at the C terminus have been identified as being responsible for the observed 73 
DPP-IV inhibition [15]. In addition, several studies have demonstrated the central role of Trp-74 
containing peptides in DPP-IV inhibition [8; 29-31]. Hemp (H), pea (P), R and soy (S) contain 75 
Trp concentrations above the requirements for an adult (6 mg g
-1
 protein day
-1
 as defined by the 76 
FAO guidelines [32], Supplementary Table S1). Therefore, they are potential dietary protein 77 
sources for the generation of hydrolysates with Trp-containing peptides. 78 
To our knowledge, apart from the previously mentioned plant proteins (R, amaranth, soybean, 79 
black bean, wheat and barley), no other plant proteins appear to have been evaluated for their in 80 
vitro DPP-IV inhibitory properties. The aim of this study was to investigate a range of plant 81 
protein isolates, i.e., from H, P, R and S for their ability to act as substrates for the generation of 82 
DPP-IV inhibitory peptides. This was achieved by enzymatically hydrolysing the plant protein 83 
isolates with different food-grade enzyme preparations in order to release DPP-IV inhibitory 84 
peptides. An in vitro simulated gastrointestinal digestion (SGID) protocol was utilised to (a) 85 
release DPP-IV inhibitory peptides from intact proteins with digestive enzymes and (b) assess the 86 
stability to digestive enzymes of the DPP-IV inhibitory peptides within prehydrolysed samples. 87 
Finally, an assessment of the presence of Trp-containing peptides within the hydrolysates was 88 
conducted using a specific fluorescence detection-based chromatographic technique. 89 
Materials and methods 90 
Reagents 91 
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Hemp (H, 47.0 % (w/w) protein), pea (P, 81.7 % (w/w) protein), brown rice (R, 80.0 % (w/w) 92 
protein) and soy (S, 90.0 % (w/w) protein) protein isolates from Pulsin (Gloucester, UK) were 93 
purchased in a local food store. Trifluoroacetic acid (TFA), tris(hydroxymethyl)aminomethane 94 
(TRIS), sodium phosphate monobasic, sodium phosphate dibasic, Gly-Pro-pNA, Leu, Trp, 95 
diprotin A (Ile-Pro-Ile) and porcine DPP-IV (≥ 10 U mg-1 protein) were obtained from Sigma 96 
Aldrich (Dublin, Ireland). 2,4,6-trinitrobenzenesulfonic acid (TNBS) was from Pierce 97 
Biotechnology (Medical Supply, Dublin, Ireland). Hydrochloric acid (HCl), high performance 98 
liquid chromatography (HPLC) grade water and acetonitrile (ACN) were from VWR (Dublin, 99 
Ireland). 100 
Enzymatic hydrolysis of the plant protein isolates 101 
The plant protein isolates were resuspended in water at a concentration of 30 g dw L
-1
 with the 102 
exception of the H protein isolate which was resuspended at 60 g dw L
-1
. The protein isolates 103 
were allowed to hydrate for 1 h at 50C. A control sample was removed from the protein 104 
dispersion and maintained at 50°C for the duration of the hydrolysis reaction (4 h). Three 105 
different enzyme preparations were used to hydrolyse the plant proteins, including a Bacillus 106 
proteinase, Protamex
®
 (Prot, Novozymes, Bagsvaerd, Denmark) and two proteinase preparation 107 
from Carica papaya latex, i.e., Corolase
®
 L10 (Cor, AB Enzymes, Darmstadt, Germany) and 108 
Promod
TM
 144MG (Prom, Biocatalysts, Cefn Coed, Wales, UK). The enzyme preparations were 109 
added to the protein solutions previously adjusted to pH 7.0 at an enzyme to substrate ratio (E:S) 110 
of 2 % (w/w for Prot or w/v for Prom and Cor). Hydrolysis was conducted at 50C at constant pH 111 
(7.0) using a pH stat (Titrando 843, Tiamo 1.4 Metrohm, Dublin, Ireland). At defined times of 112 
hydrolysis (1, 2 or 4 h), samples were withdrawn from the reaction vessel and the enzyme was 113 
inactivated by heating at 90°C for 20 min. Hydrolysates were then freeze-dried (FreeZone 18L, 114 
Labconco, Kansas City, USA) and stored at -20°C until further analysis. Because the 115 
hydrolysates were generated with plant protein isolates with different protein contents, their 116 
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potency on a protein equivalent basis was determined to select the samples for regeneration. The 117 
IC50 value expressed in protein equivalent was calculated by multiplying the IC50 value in mg dw 118 
hydrolysate mL
-1
 per the protein content of the starting substrate. The hydrolysis reaction for the 119 
seven protein hydrolysates which displayed DPP-IV IC50 values < 2.0 mg protein equivalent mL
-1
 120 
after 4 h hydrolysis (Table 1) was performed in duplicate (n=2). 121 
In vitro simulated gastrointestinal digestion (SGID) of the plant protein isolates and hydrolysates 122 
The plant protein isolates and the hydrolysates generated after 4 h incubation were subjected to in 123 
vitro SGID. This was conducted as described by Nongonierma and FitzGerald [33] following the 124 
method of Walsh et al. [34]. Briefly, the plant protein isolates or the freeze-dried plant protein 125 
hydrolysates were resuspended in water with gentle stirring at 1 % (w/v) on a protein equivalent 126 
basis at 37C for 30 min. The samples were incubated at 37°C, pH 2.0 with pepsin (Biocatalysts) 127 
for 90 min and then at pH 7.5 with Corolase PP (AB Enzymes), a pancreatic enzyme preparation, 128 
for another 150 min. The enzymes were inactivated by heating at 90°C for 20 min and the 129 
samples were subsequently freeze-dried and stored at -20°C until utilisation. 130 
Dipeptidyl peptidase IV (DPP-IV) inhibition assay 131 
The protein hydrolysates were dispersed in HPLC grade water at concentrations ranging from 132 
31.3 × 10
-3
 to 5.0 mg dw hydrolysate mL
-1
 (final concentration). The DPP-IV inhibition assay 133 
was carried out as described by Nongonierma and FitzGerald [14]. Briefly, the test samples 134 
(25μL) were pipetted onto a 96 well microplate (Sarstedt, Dublin, Ireland) containing Gly-Pro-135 
pNA (final concentration 0.200 mM). The negative control contained 100 mM Tris-HCl buffer 136 
pH 8.0 (25 μL) and Gly-Pro-pNA. The reaction was initiated by the addition of DPP-IV (final 137 
concentration 0.0025 U mL
-1
). Diprotin A was used as a positive control. Each sample was 138 
analysed in triplicate. The microplate was incubated at 37C for 60 min in a microplate reader 139 
(Biotek Synergy HT, Winoosky, VT, USA) and absorbance of the released pNA was monitored 140 
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at 405 nm. The DPP-IV IC50 values expressed in mg dw hydrolysate mL
-1
 were determined by 141 
plotting the percentage inhibition as a function of the test compound concentration. 142 
Determination of the free amino group content of the hydrolysates  143 
The free amino group content of the hydrolysates was determined following the method of Adler-144 
Nissen [35] using TNBS. Absorbance values were measured at 340 nm (Shimadzu UV mini 145 
1240, Kyoto, Japan) which allowed determination of the free amino group (AN) content using the 146 
following formula: 147 
 148 
With AN1, the amino group content of the unhydrolysed protein isolate (mg N g
-1
 protein) and 149 
AN2, the amino group content of hydrolysed proteins (mg N g
-1
 protein). 150 
Gel permeation (GP-) and reverse-phase (RP-) high-performance liquid chromatography (HPLC) 151 
of the hydrolysates 152 
GP-HPLC was used to determine the molecular mass distribution of the peptides within the 153 
hydrolysates by the method described by Spellman et al. [36]. Samples were resuspended at 0.25 154 
% (w/v) in 0.1% TFA and 30 % HPLC grade ACN in HPLC grade water. A 600 × 7.5 mm I.D. 155 
TSK G2000 SW column mounted with a 75 × 7.5 mm I.D. TSKGEL SW guard column (Tosoh 156 
Bioscience, Stuttgart, Germany) was used for separation. A 20 µL sample volume was injected 157 
onto the column. The absorbance was monitored at 214 nm. 158 
The peptide profile of different samples was determined as per Nongonierma and FitzGerald [37] 159 
using RP-HPLC (Waters, Dublin, Ireland) equipped with a 250 × 4.6 mm I.D., 5.0 μm Jupiter 160 
C18 column coupled to a C18 guard column (4 × 3 mm I.D., Phenomenex, Cheshire, UK). The 161 
absorbance was monitored at 280 and 214 nm. Samples were resuspended at 0.8% (w/v) in 0.1% 162 
TFA in HPLC water. A 20 µL sample volume was injected onto the column. 163 
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Detection of Trp and Trp-containing peptides was carried out as described in Nongonierma and 164 
FitzGerald [37] using fluorescence detection (model 2475 multi  fluo detector, Waters) of indole 165 
groups at excitation and emission wavelengths of 280 and 340 nm, respectively. Trp was used for 166 
calibration; it was injected (20 µL) in triplicate at different quantities ranging from 0-200 nmol 167 
(Supplementary Fig. S1). 168 
Statistical analysis 169 
A one way ANOVA followed by a Student Newman-Keuls post-hoc test was carried out at a 170 
significance level P < 0.05 using SPSS (version 22, SPSS Inc., Chicago, IL, USA).  171 
Results 172 
DPP-IV inhibitory activity of the plant protein hydrolysates 173 
Thirty six plant protein hydrolysates were generated using four different plant protein isolates 174 
from H, P, R and S hydrolysed with three proteo-/peptidolytic enzyme preparations (Cor, Prom 175 
and Prot) at three hydrolysis times (1, 2 and 4 h). These were subsequently evaluated for their 176 
ability to inhibit DPP-IV. The hydrolysates with the highest DPP-IV inhibitory potency (IC50 < 177 
2.0 mg protein equivalent mL
-1
 after 4 h hydrolysis) comprised of R_Prot, P_Prot, S_Prot, 178 
S_Prom, H_Prot, H_Cor and H_Prom. Their DPP-IV IC50 values are reported in Table 1 for the 179 
two independent duplicates of these hydrolysates. The DPP-IV IC50 values ranged from 0.73  180 
0.11 to 5.71  1.11 mg dw hydrolysate mL-1 for the 4 h P_Prot and the 1 h H_Cor hydrolysates, 181 
respectively. For most of the samples, the IC50 values did not significantly differ between the 1, 2 182 
and 4 h hydrolysates. This may arise from the fact that once released, the peptides were not 183 
further degraded by the enzymes following longer incubation times. The H protein hydrolysates 184 
generally had higher DPP-IV IC50 values (expressed as mg dw hydrolysate mL
-1
) than P, R and S 185 
protein hydrolysates, which could be explained by the fact that they contained ~ 50 % less protein 186 
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than P, R and S. 187 
The DPP-IV IC50 values obtained for the independent duplicate of the 4 h hydrolysates were not 188 
significantly different from each other with the exception of the S_Prot and H_Cor hydrolysates. 189 
The significant differences which were seen in the IC50 values of certain duplicate hydrolysates, 190 
especially at incubation time  2 h (Table 1) may arise from the fact that the plant protein isolates 191 
were not fully solubilised in water even after the hydration step (1 h at 50C) applied prior to 192 
enzymatic hydrolysis. The limited water solubility of the plant protein substrates may have 193 
restricted access of the enzyme to the protein substrate in certain instances. However, the IC50 194 
values of the duplicate samples were of the same order. This suggested that generation of the 195 
hydrolysates was generally reproducible in terms of their bioactive properties. 196 
DPP-IV inhibitory activity of the unhydrolysed and hydrolysed plant proteins following SGID 197 
The DPP-IV IC50 values for the unhydrolysed protein and that of the seven 4 h hydrolysates 198 
subjected to SGID are illustrated on Fig. 1A. None of the unhydrolysed protein substrates was 199 
able to inhibit DPP-IV (data not shown). Following SGID of the proteins, the resulting 200 
hydrolysates displayed DPP-IV inhibitory activity with IC50 values ranging from 1.85  0.34 to 201 
4.50  0.55 mg dw hydrolysate mL-1 for the R and H SGID samples, respectively. Interestingly, 202 
the IC50 values obtained with P, R and S subjected to SGID were not significantly different (P > 203 
0.05). 204 
When the seven 4 h hydrolysates were subjected to SGID, their IC50 value did not significantly 205 
change with the exception of the 4 h R_Prot (1.21  0.08 vs. 1.60  0.21 mg dw hydrolysate mL-1 206 
for the 4 h R_Prot before and after SGID, respectively) and 4 h H_Prot (3.09  0.68 vs. 3.82  207 
0.36 mg dw hydrolysate mL
-1
 for the 4 h H_Prot before and after SGID, respectively) which 208 
showed a significantly (P < 0.05) higher IC50 value following SGID. Generally, the DPP-IV IC50 209 
values for the 4 h H, P, R and S protein hydrolysates subjected to SGID were significantly lower 210 
(P < 0.05) than for their associated starting protein substrate subjected to SGID. In contrast, the 211 
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IC50 values for the 4 h R_Prot after SGID and that of the R protein isolate subjected to SGID 212 
were not significantly different (Fig. 1A). 213 
Physicochemical characteristics of the plant protein hydrolysates 214 
The amino group content of the seven DPP-IV inhibitory hydrolysates generated at 4 h and their 215 
duplicate samples are shown on Fig. 1B. The amino group content for these samples ranged from 216 
11.3  0.8 to 20.0  0.5 mg N g-1 sample for the 4 h S_Prom and 4 h P_Prot, respectively. For 217 
each duplicate, the values obtained for the hydrolysate were not significantly different, with the 218 
exception of the 4 h S_Prot and 4 h H_Prom. The lower amino group content for the duplicates of 219 
the 4 h S_Prot and 4 h H_Prom may be linked to the higher IC50 value seen with the 4 h S_Prot, 220 
in contrast there was no such effect seen with the 4 h H_Prom. Overall, this showed 221 
reproducibility in the enzymatic hydrolysis process. 222 
The peptide profile at 214 nm of the seven 4 h plant protein hydrolysates is illustrated on Fig. 2. 223 
The peptide profiles significantly differ. When considering 4 h hydrolysates generated with the 224 
same protein isolate, the peptide profile obtained was enzyme-dependent. This can be seen with 225 
peptide peaks which are only present in S_Prom at 30.6 min (Fig. 2F) and S_Prot at 23.5 and 26.1 226 
min (Fig. 2G). Similarly, certain peptide peaks are only seen in H_Cor at 27.9 min (Fig. 2A), 227 
H_Prom at 17.2 min (Fig. 2B) and H_Prot at 28.3 min (Fig. 2C). This suggested that different 228 
peptides may be responsible for the DPP-IV inhibitory properties seen with these samples. 229 
The molecular mass distribution of the 4 h hydrolysates together with their unhydrolysed starting 230 
protein isolate is shown on Fig. 3A. As expected, the plant isolates mainly comprised large 231 
molecular mass components. However, all isolates also had a certain proportion of low molecular 232 
mass constituents less than 1 kDa (> 14 %) which may be composed of free amino acids and 233 
short peptides (Fig. 3A). Following hydrolysis, all the intact proteins were significantly broken 234 
down to smaller peptides and/or free amino acids as can be seen by the significant reduction of 235 
the proteinaceous components (> 5 kDa) in all hydrolysate samples (Fig. 3A). Within samples 236 
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generated with the same starting substrates, protein breakdown yielded hydrolysates with very 237 
different molecular mass distributions. Hydrolysis of R, S and P with Prot for 4 h yielded samples 238 
with the highest proportion of low molecular mass peptides (< 1 kDa), while for H this was the 239 
case on hydrolysis with both Prom and Prot. 240 
Physicochemical characteristics of the unhydrolysed and hydrolysed plant proteins following 241 
SGID 242 
Although the peptide profiles for the 4 h hydrolysates before and after SGID appear different, 243 
some common peptide peaks (1, 2 and 3) were seen in both samples (Fig. 2). Most of the 244 
hydrophobic peptides and proteins eluting at longer retention time were not seen following SGID 245 
of the 4 h hydrolysates. The peptide profiles of the plant protein isolates subjected to SGID 246 
significantly differ from that of the associated 4 h hydrolysate. Peptide peaks of varying 247 
intensities eluting at 16.8, 20.1 and 25.1 min (peaks 1, 2 and 3, respectively) were seen in all 248 
SGID samples. 249 
In agreement with the peptide profiles, the samples subjected to SGID contained no or only low 250 
amounts of high molecular mass proteinaceous components (> 5 kDa) as shown on their 251 
molecular mass distribution profiles (Fig. 3B). Significant protein breakdown was seen following 252 
SGID of the plant protein isolates, yielding peptides < 1 kDa representing > 60 % of the sample. 253 
In the case of the 4 h hydrolysates obtained following SGID, peptides < 1 kDa represented > 75 254 
% of the sample. When comparing the molecular mass profiles of the 4 h hydrolysates before and 255 
after SGID (Fig. 3A vs. 3B), it was seen that SGID increased the proportion of short peptides in 256 
the hydrolysates. 257 
Trp and Trp-containing peptides within the hydrolysates and SGID samples 258 
The RP-HPLC profiles obtained during fluorescence detection of Trp-containing peptides in the 259 
twelve 4 h hydrolysates generated with H, P, R and S are illustrated in Fig. 4. All hydrolysates 260 
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analysed displayed numerous peptide peaks eluting over a wide range of retention times. It is 261 
interesting to note that the hydrolysates displaying the higher number of Trp-containing peptides 262 
were generally those which also displayed higher DPP-IV inhibitory properties (Fig. 4 and Table 263 
1). This is particularly evident with the P and R substrates where hydrolysates generated with 264 
Prot had a higher number of Trp-containing peptide peaks than Cor or Prom hydrolysates. The 4 265 
h P and R Prot hydrolysates were also more potent DPP-IV inhibitors (IC50 values < 2.5 mg dw 266 
hydrolysate mL
-1
; Table 1) than the 4 h Cor or Prom P and R hydrolysates. 267 
Fig. 5 depicts the RP-HPLC profile of Trp-containing peptides of the seven most potent DPP-IV 268 
inhibitory 4 h hydrolysates (< 2.0 mg protein equivalent mL
-1
 after 4 h hydrolysis) before and 269 
after SGID together with that of the SGID of the plant protein isolates. The hydrolysates before 270 
and after SGID showed major differences in their Trp-containing peptide profiles. This suggested 271 
that different Trp-containing peptides were present in both samples. The peak eluting at 25.1  272 
0.3 min (peak 3 in Fig. 2), corresponding to free Trp (Supplementary Fig. S1), was always more 273 
abundant in both the plant protein isolate and hydrolysate subjected to SGID compared to the 274 
hydrolysate before SGID (Fig. 5). This indicated in the case of the hydrolysates that certain Trp-275 
containing peptides were further degraded by the proteolytic action of the gastrointestinal 276 
enzymes. Interestingly, all three 4 h H protein hydrolysates (Fig. 5A to 5C) contained 277 
significantly more free Trp (peak eluting at 25.1 min) than the 4 h R, S and P protein hydrolysates 278 
(Fig. 5D to 5G). This may be, in part, due to the high amount of free Trp found in the starting H 279 
protein isolate used in this study (Supplementary Fig. S2). 280 
Discussion 281 
A limited number of studies exist relating to the ability of plant protein hydrolysates to act as a 282 
source of DPP-IV inhibitory peptides [15-17]. The IC50 values obtained with H, P, R and S 283 
protein hydrolysates herein are of the same order as previous studies with other plant protein 284 
hydrolysates [15; 17]. The IC50 value of 0.73  0.11 mg dw hydrolysate mL
-1
 for the 4 h P_Prot 285 
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hydrolysate is one of the lower, and therefore more potent, values reported to date for a plant 286 
protein hydrolysate. 287 
Hydrolysis with Prot was shown to yield relatively potent DPP-IV inhibitory hydrolysates with 288 
the 4 plant protein substrates studied herein (Table 1). Prot is a proteolytic preparation containing 289 
mainly a Bacillus-like subtilisin activity, which has been shown to cleave peptide bonds after 290 
large hydrophobic side chains, such as Phe [38]. SGID of H, P, R and S released peptides with 291 
DPP-IV inhibitory activity (Fig. 1A). This result is consistent with a previous study showing the 292 
release of DPP-IV inhibitory peptides following SGID of plant proteins [17]. However, there was 293 
a benefit in hydrolysing food proteins prior to their SGID, i.e., it yielded more potent DPP-IV 294 
inhibition. The similar IC50 values pre and post SGID may indicate that the peptides responsible 295 
for the DPP-IV inhibition were stable to SGID or that the overall effect on DPP-IV inhibition of 296 
the new peptides released after SGID was similar to that of the peptides within the original 297 
hydrolysate. 298 
The four protein substrates studied herein are good sources of Trp (Supplementary Table S1). 299 
Recently, several Trp-containing peptides have been shown to display relatively low DPP-IV IC50 300 
values [8; 15; 29-31; 39; 40]. Peptide alignment strategies applied to DPP-IV inhibitory peptides 301 
with an IC50 value < 200 µM, generally showed the presence of a Trp residue at the N-terminus 302 
and/or a Pro at position 2 of the peptide [8; 41]. Interestingly, H, P, R and S hydrolysates 303 
containing several Trp-containing peptides were generally good DPP-IV inhibitors (Fig. 4). The 304 
presence of Trp-containing peptides in an hydrolysate, however, does not directly correlate with 305 
its DPP-IV inhibitory potential as dipeptides with a C-terminal Trp generally have a low or no 306 
DPP-IV inhibition in contrast with the reverse peptide [14; 30; 42]. An increase in free Trp was 307 
observed following SGID of the intact proteins and the 4 h hydrolysates. This may, in part, be 308 
explained by the fact that chymotrypsin and pepsin can cleave post Trp. Non Trp-containing 309 
peptides may also have contributed to the DPP-IV inhibitory properties reported herein [8]. A 310 
better knowledge of the peptide sequences present within the hydrolysates should help to 311 
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determine their direct contribution to overall DPP-IV inhibitory properties. 312 
To date, three studies have shown that administration of DPP-IV inhibitory milk protein or 313 
porcine skin gelatin hydrolysates in vivo could reduce serum glucose level [12; 13; 23]. In 314 
addition, Huang et al. [23] showed that a daily administration of 300 mg for 42 days of a porcine 315 
skin gelatin hydrolysate to streptozotocin-induced diabetic rats resulted in the inhibition of 316 
plasma DPP-IV activity. 317 
Conclusion 318 
It was demonstrated within this study that selected plant protein hydrolysates could inhibit DPP-319 
IV with different potencies depending on the combination of plant protein isolate and enzyme 320 
employed. To our knowledge, the in vitro DPP-IV inhibitory activity of H and P protein 321 
hydrolysates has been reported for the first time herein. In general Prot yielded relatively good 322 
DPP-IV inhibitory hydrolysates with the four protein substrates employed. In most instances, it 323 
was demonstrated that there was a benefit to pre-hydrolyse the plant proteins as SGID of the 324 
hydrolysates generally yielded higher DPP-IV inhibitory potency than that of the intact protein 325 
subjected to SGID alone. The possible contribution of Trp-containing peptides to DPP-IV 326 
inhibitory properties was studied. In general, hydrolysates with good DPP-IV inhibitory 327 
properties had a wider range of Trp-containing peptides compared to hydrolysates with a lower 328 
potency. Future work will involve identification of the peptides within the hydrolysates and 329 
subsequent confirmatory studies with synthetic peptides. The DPP-IV inhibitory potential of the 330 
plant-derived hydrolysates also needs to be assessed in vivo to demonstrate that the in vitro 331 
results observed herein, in particular after SGID, translate to a reduction in post-prandial serum 332 
glucose level in humans. 333 
334 
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Table captions 
Table 1 Concentration of hemp (H), pea (P), rice (R) and soy (S) protein hydrolysates 
inducing 50 % inhibition (IC50) of dipeptidyl peptidase IV (DPP-IV) after 1, 2 and 4 h 
hydrolysis with Corolase L10 (Cor), Promod 144MG (Prom) or Protamex (Prot). Each 
hydrolysate with a DPP-IV IC50 < 2.0 mg protein equivalent mL
-1
 after 4 h hydrolysis was 
generated twice independently (Trial 1 and 2). The IC50 values are the means ± SD of 
triplicate determinations expressed in mg dw hydrolysate mL
-1
. 
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Table 1 
Sample 
DPP IV IC50 (mg dw hydrolysate mL
-1
)
#
 
Trial 1  Trial 2 
1 h  2 h 4 h  1 h  2 h 4 h 
H_Cor 5.35 ± 0.69 5.43 ± 0.30* 2.93 ± 0.51*
 
 5.71 ± 1.11
 
4.38 ± 0.54*
 
3.64 ± 0.24*
 
H_Prom 3.11 ± 0.44 1.84 ± 0.53* 2.22± 0.32
 
 3.31 ± 0.34 3.06 ± 0.61*
 
2.10 ± 0.23
 
H_Prot 3.80 ± 0.13* 2.87 ± 0.42* 3.09 ± 0.68  2.67 ± 0.36*
 
2.26 ± 0.6*
 
3.29 ± 0.39
 
P_Cor > 2.5 > 2.5 > 2.5  nd nd nd 
P_Prom > 2.5 > 2.5 > 2.5  nd nd nd 
P_Prot 0.96 ± 0.13 0.90 ± 0.12 0.73 ± 0.11  0.98 ± 0.17
 
 1.08 ± 0.19 0.78 0.12
 
R_Cor > 2.5 > 2.5 > 2.5  nd nd nd 
R_Prom > 2.5 > 2.5 > 2.5  nd nd nd 
R_Prot 1.55 ± 0.12 1.03 ± 0.03 1.21 ± 0.08  1.37 ± 0.31 1.17 ± 0.18 0.91 ± 0.12
 
S_Cor > 2.5 > 2.5 > 2.5  nd nd nd 
S_Prot 0.96 ± 0.13* 0.92 ± 0.16 0.98 ± 0.14*  1.76 ± 0.31* 1.52 ± 0.14 1.79 ± 0.23* 
S_Prom 0.86 ± 0.22 1.37 ± 0.14* 0.85 ± 0.20
 
 1.15 ± 0.15 2.21 ± 0.20* 1.30 ± 0.11
 
#
Values represent mean IC50 values ± SD of triplicate determination (n=3). 
*
Values for duplicate samples generated during two independent 
trials are significantly different (P < 0.05). nd: not determined 
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Figure captions 
Figure 1. a Dipeptidyl peptidase IV (DPP-IV) half maximum inhibitory concentration (IC50) of simulated 
gastrointestinal digests (SGID) of hemp (H) , pea (P), rice (R) and soy (S) proteins hydrolysed for 4 h with Corolase 
L10 (Cor), Promod 144MG (Prom) or Protamex (Prot) and their associated SGID samples. b Free amino group 
content of the hydrolysates. Each hydrolysate was independently generated twice (Trial 1 and 2). IC50 values 
expressed in mg dw hydrolysate mL
-1
 represent the mean ± SD of three replicates (n=3). Data with different letters 
are significantly different (P < 0.05).  
 
Figure 2. Reverse-phase high performance liquid chromatographic (RP-HPLC) profiles (absorbance at 214 nm vs. 
elution time) of hemp (H) , pea (P), rice (R) and soy (S) proteins hydrolysed for 4 h with Corolase L10 (Cor), Promod 
144MG (Prom) or Protamex (Prot). a H_Cor, b H_Prom, c H_Prot, d P_Prot, e R_Prot, f S_Prom and g S_Prot. On 
each panel, the profile of the hydrolysate (black), its simulated gastrointestinal digested (SGID, dark grey) sample 
and the SGID of the corresponding starting protein substrate (light gray) are depicted. ACN: acetonitrile. For the 
hydrolysates, the arrows show peptide peaks which differ between substrates. For the SGID samples the numbers (1, 
2 and 3) show common peptide peaks in the different samples. 
 
Fig. 3. a Molecular mass distribution profiles of protein isolates from hemp (H), pea (P), rice (R) and soy (S) and 
their associated 4 h hydrolysates generated with Corolase L10 (Cor), Promod 144MG (Prom) and Protamex (Prot). b 
Molecular mass distribution of plant protein isolates and selected 4 h hydrolysates subjected to simulated 
gastrointestinal digestion (SGID). 
 
Fig. 4 Reverse-phase high performance liquid chromatographic (RP-HPLC) profile (relative fluorescence vs. elution 
time) of the Trp-containing peptides detected in the 4 h plant protein hydrolysates generated from a hemp (H), b pea 
(P), c rice (R) and d soy (S) using Protamex (Prot, black), Promod 144MG (Prom, dark gray) and Corolase L10 (Cor, 
light gray). Trp detection in fluorescence mode at excitation and emission wavelengths of 280 and 340 nm, 
respectively, using the method for the specific detection of indole groups as described by Nongonierma and 
FitzGerald [37]. ACN: acetonitrile.  
 
 
Fig. 5. Reverse-phase high performance liquid chromatographic (RP-HPLC) profiles (relative fluorescence vs. 
elution time) of Trp-containing peptides within hemp (H), pea (P), rice (R) and soy (S) proteins hydrolysed for 4 h 
with Corolase L10 (Cor), Promod 144MG (Prom) or Protamex (Prot). ). a H_Cor, b H_Prom, c H_Prot, d P_Prot, e 
R_Prot, f S_Prom and g S_Prot. On each panel, the profile of the hydrolysate (black), its simulated gastrointestinal 
digestion sample (SGID, dark grey) and the SGID of the corresponding starting protein substrate (light 
  26 
gray) are depicted. Trp detected in fluorescence mode at excitation and emission wavelengths of 280 and 340 nm, 
respectively, using the method for the specific detection of indole groups as described by Nongonierma and 
FitzGerald [37]. ACN: acetonitrile. 
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Supplementary data  
 
Supplementary Table S1 Essential amino acid contents in hemp (H), pea (P), rice (R) and soy (S) proteins, and their adult daily requirements (source: FAO 
[32]) and average amino acid composition as indicated by the supplier (Pulsin) of the protein isolates. 
 
 
Amino acid 
Composition (mg g
-1
 protein) 
Requirements for an adult  
(mg g
-1 
protein day
-1
) 
Hemp Pea Rice Soy 
Histidine 28 25 22 18 15 
Isoleucine 23 45 58 35 30 
Leucine 53 84 91 67 59 
Lysine 34 72 51 51 45 
Methionine + Cysteine 36 21 47 28 22 
Phenylalanine + Tyrosine 68 93 85 74 38 
Threonine 32 39 48 34 23 
Tryptophan 9 10 16 7 6 
Valine 32 50 60 36 39 
Total essential amino acids 315 439 478 350 277 
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Fig. S1 (A) Reverse-phase high performance liquid chromatographic (RP-HPLC) profile of free Trp (200 nmol) detected in fluorescence mode at excitation and 
emission wavelengths of 280 and 340 nm, respectively, using the method for the specific detection of indole groups as described by Nongonierma and 
FitzGerald [37] and (B) Trp calibration curve obtained in fluorescence mode. ACN: acetonitrile. 
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Fig. S2 Reverse-phase high performance liquid chromatographic (RP-HPLC) profile of free Trp detected in the hemp protein isolate. Trp detection in 
fluorescence mode at excitation and emission wavelengths of 280 and 340 nm, respectively, using the method for the specific detection of indole groups as 
described by Nongonierma and FitzGerald [37]. ACN: acetonitrile. 
